Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for Kymera Therapeutics, Inc. [KYMR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 7.75%
SELL
75.00%
return -2.93%
Last Updated31 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

-0.16% $ 32.11

BUY 155151 min ago

@ $36.93

Issued: 14 Feb 2024 @ 15:32

Return: -13.05%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: 3.50 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system...

Stats
Today's Volume 470 562
Average Volume 571 014
Market Cap 1.97B
EPS $0 ( 2024-05-02 )
Next earnings date ( $-0.730 ) 2024-06-18
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -12.79
ATR14 $0.0570 (0.18%)
Insider Trading
Date Person Action Amount type
2024-05-23 Chadwick Jeremy G Sell 2 575 Common Stock
2024-03-28 Baker Bros. Advisors Lp Buy 32 000 Non-Qualified Stock Option (right to buy)
2024-03-28 Baker Bros. Advisors Lp Buy 0 Common Stock
2024-03-28 Baker Bros. Advisors Lp Buy 0 Common Stock
2024-03-28 Baker Bros. Advisors Lp Buy 7 379 066 Prefunded Warrants
INSIDER POWER
43.87
Last 97 transactions
Buy: 2 813 290 | Sell: 1 011 479

Volume Correlation

Long: 0.50 (neutral)
Short: 0.44 (neutral)
Signal:(62.761) Neutral

Kymera Therapeutics, Inc. Correlation

10 Most Positive Correlations
SWTX0.907
YMAB0.906
SLN0.904
MRUS0.898
ICFI0.895
TNYA0.895
HQY0.891
LRMR0.889
PEPG0.886
REYN0.882
10 Most Negative Correlations
BSGM-0.907
CNTY-0.904
VALN-0.894
SGML-0.875
DSWL-0.869
GSM-0.867
RELL-0.86
BLKB-0.857
HIFS-0.852
OMCL-0.852

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kymera Therapeutics, Inc. Correlation - Currency/Commodity

The country flag -0.26
( neutral )
The country flag -0.28
( neutral )
The country flag 0.00
( neutral )
The country flag -0.23
( neutral )
The country flag 0.02
( neutral )
The country flag 0.36
( neutral )

Kymera Therapeutics, Inc. Financials

Annual 2023
Revenue: $78.59M
Gross Profit: $75.03M (95.46 %)
EPS: $-2.52
FY 2023
Revenue: $78.59M
Gross Profit: $75.03M (95.46 %)
EPS: $-2.52
FY 2022
Revenue: $46.83M
Gross Profit: $43.85M (93.64 %)
EPS: $-2.82
FY 2021
Revenue: $72.83M
Gross Profit: $72.83M (100.00 %)
EPS: $-1.976

Financial Reports:

No articles found.

Kymera Therapeutics, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.3886799812317 seconds
Number of API calls: 2
Number of DB calls: 8